Stryker has reported a decline in compensation for both its top leadership and its median employee, according to its latest regulatory filing. The drop marks a second consecutive year of reduced median pay, alongside lower payouts for senior executives.
The company, among the largest global medical device makers, posted strong financial performance in 2025. Revenue rose to $25.1 billion, reflecting double-digit growth from the previous year. The period also saw major strategic moves, including the acquisition of Inari Medical and the divestment of its US spine implants business.
Even with business expansion, executive compensation declined. Kevin Lobo, CEO, Stryker, earned $21.4 million in 2025, slightly lower than the previous year. The reduction was largely due to smaller cash bonuses and stock-based incentives. Other senior leaders, including newly appointed president and COO Spencer Stiles, along with division heads, also saw pay cuts ranging between 7 and 8 per cent.
Changes in leadership roles shaped the compensation structure during the year. The company elevated new leaders while managing transitions in key positions, including the retirement of its former finance chief and the appointment of a successor.
Median employee pay stood at $81,018, reflecting a modest decline from the prior year. This shift widened the gap between CEO and employee earnings. The CEO now earns over 260 times the median worker’s pay, a ratio that has slightly increased.
The company indicated that compensation continues to be tied to performance and long-term shareholder value. Investors are expected to review and vote on executive pay practices at the upcoming annual meeting in May.
